Vanguard Personalized Indexing Management, LLC Vaxcyte, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $5.26 Billion
- Q2 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 4,850 shares of PCVX stock, worth $538,738. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,850
Previous 3,955
22.63%
Holding current value
$538,738
Previous $270,000
35.56%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding PCVX
# of Institutions
287Shares Held
110MCall Options Held
248KPut Options Held
109K-
Black Rock Inc. New York, NY9.94MShares$1.1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.8MShares$1.09 Billion0.01% of portfolio
-
Janus Henderson Group PLC London, X08.87MShares$985 Million0.37% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.2MShares$911 Million9.34% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$510 Million0.06% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $6.59B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...